Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-757909
Filing Date
2016-11-03
Accepted
2016-11-03 06:09:46
Documents
55
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d274330d10q.htm 10-Q 856318
2 EX-31.1 d274330dex311.htm EX-31.1 8730
3 EX-31.2 d274330dex312.htm EX-31.2 9214
4 EX-32.1 d274330dex321.htm EX-32.1 5317
  Complete submission text file 0001193125-16-757909.txt   5669747

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT amrn-20160930.xml EX-101.INS 966985
6 XBRL TAXONOMY EXTENSION SCHEMA amrn-20160930.xsd EX-101.SCH 50453
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE amrn-20160930_cal.xml EX-101.CAL 57176
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE amrn-20160930_def.xml EX-101.DEF 373865
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE amrn-20160930_lab.xml EX-101.LAB 490203
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amrn-20160930_pre.xml EX-101.PRE 425207
Mailing Address FIRST FLOOR, BLOCK 3, THE OVAL, SHELBOURNE ROAD, BALLSBRIDGE DUBLIN L2 00000
Business Address FIRST FLOOR, BLOCK 3, THE OVAL, SHELBOURNE ROAD, BALLSBRIDGE DUBLIN L2 00000 353 1 6699 020
AMARIN CORP PLC\UK (Filer) CIK: 0000897448 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21392 | Film No.: 161970015
SIC: 2834 Pharmaceutical Preparations